Study answers Medicare concerns about paying for CT colonography

July 1, 2012

A new study of 1,400 Medicare-aged patients reinforces CT colonography as a screening tool for colon cancer, adding to the continued debate over Medicare coverage of the procedure.

In 2009, the Centers for Medicare and Medicaid Services indicated that CT colonography would not be covered, in part, because outcomes data specific to the Medicare population was not available.

"Our study answers several of the questions Medicare asked about this procedure," said Brooks Cash, MD, one of the authors of the study. The study found that the percentage of patients that would have been referred to as a result of CT colonography was 14%, which is similar to what other studies have found in the younger population, said Dr. Cash. "The prevalence of neoplasia (abnormal growths of cells) detected by CT colonography was 9.3% in patients over the age of 65," which is also similar to the results of other studies involving younger patients," he said.

Potentially important extracolonic findings were identified in 2.9% of the study group. "The confirmation of low rates of referral to colonoscopy, the prevalence of advanced neoplasia and the prevalence of extracolonic findings makes CT colonography a viable option for Medicare-aged patients," said Dr. Cash.

The Centers for Medicare and Medicaid Services had also expressed concern about the of colonoscopy, said Dr. Cash. "The average effective radiation dose with CT colonography at the National Naval Medical Center in Bethesda, MD (where the study was conducted) was calculated to be 4.24 mSv per CT colonography examination. To put that in perspective, the average yearly of American adults is about 6.2mSv," Dr. Cash said.

Several previous studies have shown that up to 40% of individuals undergoing CT colonography say they would not have been screened for if CT colonography had not been available to them. "This is the real value of CT colonography – offering an alternative, high quality, total colonic preventative screening to a large percentage of the population that either refuses or is unable to undergo colonoscopy," said Dr. Cash.

Currently about 50-60% of patients eligible for colon cancer screening undergo any kind of screening examination; "we have calculated in our practice that we could increase screening compliance rates by about 15% if was covered by Medicare or third party payers," Dr. Cash said.

The study appears in the July, 2012 American Journal of Roentgenology, published by the American Roentgen Ray Society.

Explore further: CT colonography shown to be comparable to standard colonoscopy

Related Stories

CT colonography shown to be comparable to standard colonoscopy

February 23, 2012
Computerized tomographic (CT) colonography (CTC), also known as virtual colonoscopy, is comparable to standard colonoscopy in its ability to accurately detect cancer and precancerous polyps in people ages 65 and older, according ...

Colon Cancer Alliance and American College of Radiology demand Medicare cover virtual colonoscopy

February 23, 2012
In response to a study published online Feb. 23 in Radiology which showed that virtual colonoscopies are comparably affective to standard colonoscopy at detecting colorectal cancer and precancerous polyps in adults ages 65 ...

Study: Virtual colonoscopy effective screening tool for adults over 65

February 23, 2012
Computed tomography (CT) colonography can be used as a primary screening tool for colorectal cancer in adults over the age of 65, according to a new study published online in the journal Radiology.

Recommended for you

Retaining one normal BRCA gene in breast, ovarian cancers influences patient survival

August 22, 2017
Determining which cancer patients are likely to be resistant to initial treatment is a major research effort of oncologists and laboratory scientists. Now, ascertaining who might fall into that category may become a little ...

Zebrafish larvae could be used as 'avatars' to optimize personalized treatment of cancer

August 21, 2017
Portuguese scientists have for the first time shown that the larvae of a tiny fish could one day become the preferred model for predicting, in advance, the response of human malignant tumors to the various therapeutic drugs ...

Scientists discover vitamin C regulates stem cell function, curbs leukemia development

August 21, 2017
Not much is known about stem cell metabolism, but a new study from the Children's Medical Center Research Institute at UT Southwestern (CRI) has found that stem cells take up unusually high levels of vitamin C, which then ...

Searching for the 'signature' causes of BRCAness in breast cancer

August 21, 2017
Breast cancer cells with defects in the DNA damage repair-genes BRCA1 and BRCA2 have a mutational signature (a pattern of base swaps—e.g., Ts for Gs, Cs for As—throughout a genome) known in cancer genomics as "Signature ...

How a non-coding RNA encourages cancer growth and metastasis

August 21, 2017
A mechanism that pushes a certain gene to produce a non-coding form of RNA instead of its protein-coding alternative can promote the growth of cancer, report researchers at the Medical University of South Carolina (MUSC) ...

Spaser can detect, kill circulating tumor cells to prevent cancer metastases, study finds

August 21, 2017
A nanolaser known as the spaser can serve as a super-bright, water-soluble, biocompatible probe capable of finding metastasized cancer cells in the blood stream and then killing these cells, according to a new research study.

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.